PACT Pharma lands $75 mln Series C

South San Francisco-based PACT Pharma, a clinical-stage company, has raised $75 million in Series C financing.

13 January 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles